Veradigm Inc (PK:MDRX)
Business Focus: Medical Software & Technology Services
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 222 MERCHANDISE MART PLAZA, SUITE 2024 CHICAGO IL 60654 |
| Tel: | N/A |
| Website: | https://veradigm.com |
| IR: | See website |
| Key People | ||
| P. Gregory Garrison Executive Chairman of the Board | Thomas Langan President | Shih-yin Ho Interim Chief Executive Officer, Principal Accounting Officer, Director |
| Leland Westerfield Interim Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer | Lisa Hammond Chief Human Resource Officer, Senior Vice President | Tejal Vakharia Senior Vice President, General Counsel - Marketing and Government Affairs |
| Business Overview |
| Veradigm Inc. is a healthcare data and technology solutions technology company. The Company is focused on research, analytics, and building scalable data-driven solutions. It combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. It also provides full-service revenue cycle management. |
| Financial Overview |
| For the nine months ended 30 September 2022, Veradigm Inc revenues increased 6% to $445.5M. Net income before extraordinary items decreased 36% to $32.7M. Revenues reflect Veradigm segment increase of 7% to $426.3M. Net income was offset by Unallocated Amounts segment loss increase from $3.6M to $43.6M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.39 to $0.29. |
| Employees: | 8,000 as of Dec 31, 2021 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $525.79M as of Sep 30, 2022 |
| Annual revenue (TTM): | $837.19M as of Sep 30, 2022 |
| EBITDA (TTM): | $153.23M as of Sep 30, 2022 |
| Net annual income (TTM): | $119.94M as of Sep 30, 2022 |
| Free cash flow (TTM): | $114.20M as of Sep 30, 2022 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 107,639,978 as of Apr 9, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.